大鼠睾丸前促甲状腺激素释放激素原及其受体的表达与发育变化

为研究促甲状腺激素释放激素（thyrotrophin-releasing hormone,TRH)及其受体（TRH receptor,TRHR)在大鼠睾丸组织中的表达规律和在生殖发育调节中的作用,依据大鼠下丘脑中的前TRH原（PreproTRH,ppTRH)和垂体中的TRH－R cDNA设计引物,采用RT－PCR法从大鼠睾丸组织中获得了ppTRH和TRH－R的cDNA克隆,测序后构建表达载体,在大肠杆菌中表达了可溶性的pTRH t TRH-R融合蛋白,利用实时动态定量RT－PCR（real time quantitative RT-PCR)法观察了ppTRH和TRH－R在不同发育阶段大鼠睾丸中的表达变化,发现在睾丸间质细胞发育的初期阶段（第8天）,没有ppTRH和TRH－R的表达,但从第15天起能观察到pp-TRH和TRH－R的表达,并且表达量在20天,35天,60天和90天逐渐增加,这些结果表明：大鼠睾丸组织能特异性表达ppTRH和TRH－R,并且表达量与发育过程相关,ppTRH和TRH－R体外表达产物的获得为后续研究其功能奠定了基础。     

促甲状腺激素释放激素受体-1(TRH-R1)蛋白在大鼠出生后睾丸不同发育阶段的表达和定位

目的研究促甲状腺激素释放激素受体-1(thyrotrophin-releasing hormone receptor type-1, TRH-R1)在大鼠睾丸出生后不同发育阶段的表达,探讨其在生殖发育调节中的作用.方法应用蛋白质免疫印迹杂交技术以及免疫组织化学ABC法检测TRH-R1在8d、15d、20d、35d、60d和90d大鼠睾丸中的表达和定位,并结合图像分析技术对免疫组化结果进行统计学分析观察其在发育过程中的变化.结果免疫印迹杂交发现TRH-R1蛋白表达于15d以后各阶段的大鼠睾丸;而运用免疫组化在第8d即检测到TRH-R1的表达,以后发育过程中的各个阶段均有阳性反应细胞, TRH-R1定位于大鼠睾丸的间质细胞;免疫反应阳性物均位于胞膜和胞质,胞核区为阴性;图像分析结果表明,随着大鼠睾丸的发育,TRH-R1表达量呈增多趋势,且具有统计学差异(P＜0.01).结论本实验证明TRH-R1在出生后8d大鼠的睾丸内即有表达,并持续表达于其后各个发育阶段;TRH-R1定位于睾丸的间质细胞,其表达量随着增龄变化呈增多趋势,即同发育过程相关.     

促甲状腺激素释放激素受体mRNA在大鼠睾丸中的表达(英文)

本应用原位杂交技术在大鼠睾丸恒冷箱切片上研究了促甲状腺激素释放激素受体（TRH－R）RNA的表达和定位。由DNA合成仪合成两个含48个碱基的寡核苷酸探针,两个探针分别与小鼠垂体TRH－R1005－1052和1332－1379区段的cDNA互补,生物素在5′末端标记寡核苷酸探针。结果显示TRH－R寡核苷酸探针与其互补的mRNA杂交信号集中在大鼠睾丸的间质细胞中,生精细胞地交信号,杂交信号的强度依探针浓度而增加,该结果表明RTH可能通过自分泌调节生殖功能和发育,TRH－R作用途径可能与在垂体的作用类似。     

雄激素受体在大鼠睾丸中转录模式的分析

目的：研究Ar（雄激素受体）基因在大鼠睾丸组织中的转录模式。方法：取刚出生的雄性Wistar大鼠,于出生2~65日的不同时间点,脊椎脱臼处死3只不同窝别的幼鼠,提取睾丸组织总mRNA;将mRNA反转录成cDNA,随后采用Real-time PCR方法检测大鼠睾丸组织中Ar mRNA的转录情况。结果：Ar mRNA表达在出生后第2天开始缓慢上升到第16天达到最高值,第16天到第30天迅速下降,第31天出现一个小高峰后到第65天持续缓慢下降。结论：Ar基因在大鼠早期发育睾丸组织中表达量逐渐升高,可能与精原干细胞的增殖及初级精母细胞的发生相关。     

胰岛素样生长因子结合蛋白-7′在大鼠胚胎植入过程中的差异表达与调节

胰岛素样生长因子结合蛋白-7(IGFBP-7)已经证实在人的妊娠过程中起了重要作用,但在大鼠中尚未见报道.在过去的研究中曾利用抑制消减杂交(SSH)方法分析了植入前和植入期的基因表达谱,发现IGFBP-7存在差异表达.通过RNA印迹和原位杂交,分析了IGFBP-7部分序列(编码区531～928nt,称作IGFBP-7′)在大鼠妊娠早期子宫中的时空表达模式.用RT-PCR方法检测了其在不同组织器官及假孕、人工诱导蜕膜化和延迟着床激活大鼠子宫中的表达模式.结果显示:在大鼠妊娠第5天IGFBP-7′mRNA的表达量开始增加,第5.5和6天表达量显著高于植入前期.IGFBP-7′mRNA主要表达于子宫腔上皮和腺上皮.IGFBP-7′mRNA表达无组织特异性,在大鼠的下丘脑、垂体、卵巢、子宫、心、肝、脾、肺、肾等器官均有表达,在假孕的D1～D6大鼠子宫中均有表达,但无显著性差异,诱导蜕膜化后IGFBP-7′mRNA的表达量也无明显变化,但在延迟着床激活的大鼠子宫中表达显著增加.这些结果提示,在植入期IGFBP-7′的表达增加主要是由胚泡引起的,而非蜕膜化.在大鼠妊娠早期,IGFBP-7′的表达增加可能有利于胚胎植入的发生.     

一个小鼠睾丸特异表达新基因mtIQ2的克隆和表达谱分析

运用数据库消减杂交筛选出一个在小鼠睾丸中特异表达的新基因--mtIQ2 (Genbank Accession No: DQ153247), Northern blot结果表明该基因的cDNA序列全长为1.2kb,小鼠多组织RT-PCR结果表明:该基因在睾丸中特异表达,而在其他组织中没有表达.运用隐睾模型对该基因的表达研究表明:在手术后第9d,该基因表达急剧下降,到18d完全消失.这些实验提示该基因在睾丸的发育和性成熟过程中可能起重要作用.     

Smad4蛋白在不同龄大鼠睾丸的定位研究

探讨转化生长因子-β超家族肽类的细胞内信号转导分子Smad4蛋白在发育不同阶段大鼠睾丸的表达与分布。分别选用出生后3、7、14、28天以及成年大鼠,应用免疫组织化学ABC法结合葡萄糖氧化酶-DAB-硫酸镍铵增强技术及蛋白质免疫印迹技术,检测Smad4蛋白在大鼠睾丸的表达、定位和发育变化,并通过图像分析技术对免疫组织化学结果进行统计学分析。结果显示,发育各个阶段的间质细胞中都有较强的表达,免疫阳性产物位于细胞质内,而各级生精细胞则无阳性反应,且随着大鼠睾丸发育阶段的变化而蛋白表达量逐渐增多,为TGF-β超家族成员在精子发生和发育过程中的分子机理提供了直接证据。     

大鼠促甲状腺激素释放激素受体1基因的克隆及其在COS-7细胞系中的表达

目的:克隆大鼠促甲状腺激素释放激素受体1(TRH-R1)基因,构建其真核表达载体,并检测该基因在非洲绿猴肾细胞系COS-7中的表达。方法:应用RT-PCR方法,以大鼠脑源RNA为模板,扩增获得TRH-R1基因,定向克隆到pDsRed2-N1中,以LipofectAMINE 2000试剂转染pDsRed2-N1-TRH-R1表达载体至COS-7细胞系中进行瞬时表达。结果:测序结果表明,从大鼠脑源总RNA中克隆到正确的TRH-R1基因全长编码序列;显微照相观察到所构建的TRH-R1表达载体质粒在COS-7细胞系中获得有效表达。结论:大鼠TRH-R1基因的克隆、真核表达载体的构建及在COS-7细胞系中表达获得成功,为进一步研究其功能奠定了基础。     

Smad4蛋白在不同龄大鼠睾丸的定位研究

探讨转化生长因子－β超家族肽类的细胞内信号转导分子Smad4蛋白在发育不同阶段大鼠睾丸的表达与分布。分别选用出生后3、7、14、28天以及成年大鼠,应用免疫组织化学ABC法结合葡萄糖氧化酶－DAB－硫酸镍铵增强技术及蛋白质免疫印迹技术,检测Smad4蛋白在大鼠睾丸的表达、定位和发育变化,并通过图像分析技术对免疫组织化学结果进行统计学分析。结果显示,发育各个阶段的间质细胞中都有较强的表达,免疫阳性产物位于细胞质内,而各级生精细胞则无阳性反应,且随着大鼠睾丸发育阶段的变化而蛋白表达量逐渐增多,为TGF－β超家族成员在精子发生和发育过程中的分子机理提供了直接证据。     

Smads蛋白在大鼠睾丸发育不同阶段的表达和定位

探讨转化生长因子－β超家族肽类的细胞内信号转导分子Smads蛋白在发育不同阶段大鼠睾丸的表达及在精子发生中的作用机理。分别选用出生后3、7、14和28d以及成年大鼠,应用蛋白质免疫印迹杂交技术及免疫组织化学ABC法结合葡萄糖氧化酶－DAB－硫酸镍铵增强技术,检测Smad1、Smad2、Smad4和Smad5蛋白在大鼠睾丸的表达、定位和发育变化,并通过图像分析技术对免疫组织化学结果进行统计学分析。免疫印迹杂交发现,Samd1、Smad2和Smad4在3、7、14和28d以及成年大鼠睾丸的生精细胞中即可见免疫阳性反应;Smad2和从7d起开始表达,免疫阳性产物位于各级生精细胞的胞质内;Smad4在发育的各个阶段的间质细胞中均有较强的表达;Smad5仅在28d和成年大鼠的间质细胞中有弱的表达。结果提示：Smads蛋白在睾丸中的分布不同,表达量存在差异,为揭示TGF－β超家族在粗子发生和发育过程中的分子机制提供了直接证据。     

Differential regulation of thyrotropin-releasing hormone receptor mRNA levels by thyroid hormone in vivo and in vitro (GH3 cells).

We studied the effect of thyroid status on thyrotropin-releasing hormone receptor (TRH-R) mRNA levels both in vivo and in vitro (GH3 cells) using a cloned rat TRH-R cDNA by RT-PCR. Experimental hypothyroid rats were produced by total thyroidectomy and were then killed 7 days after the operation. TRH receptor binding in the anterior pituitary and serum TSH level were elevated approximately 2-fold and 8-fold, respectively, in 7 day thyroidectomized rats. TRH-R mRNA levels in hypothyroid rats were also increased significantly compared with those of normal rats. In GH3 cells, however, no significant change of TRH-R mRNA level was observed between cultures treated with triiodothyronine (T3, 10(-9) and 10(-7) M) and the untreated group. The present data indicate that 1) the in vivo effects of thyroid status on TRH-R mRNA levels differ from the in vitro one, and that 2) the down regulation of TRH-R binding by thyroid hormone in GH3 cells may be mediated by translational or post-translational mechanisms.     

Thyrotropin-releasing hormone (TRH) and phorbol myristate acetate decrease TRH receptor messenger RNA in rat pituitary GH3 cells: evidence that protein kinase-C mediates the TRH effect.

In a previous report we showed that TRH-induced down-regulation of the density of its receptors (TRH-Rs) on rat pituitary tumor (GH3) cells was preceded by a decrease in the activity of the mRNA for the TRH-R, as assayed in Xenopus oocytes. Here we report the effects of TRH, elevation of cytoplasmic free Ca2+ concentration, phorbol myristate acetate (PMA), and H-7 [1-(5-isoquinolinesulfonyl)2-methylpiperazine dihydrochloride], an inhibitor of protein kinases, on the levels of TRH-R mRNA, which were measured by Northern analysis and in nuclease protection assays using probes made from mouse pituitary TRH-R cDNA, in GH3 cells. These agents were studied to gain insight into the mechanism of the TRH effect, because signal transduction by TRH involves generation of inositol 1,4,5-trisphosphate and elevation of cytoplasmic free Ca2+ concentration, which leads to activation of Ca2+/calmodulin-dependent protein kinase, and of 1,2-diacylglycerol, which leads to activation of protein kinase-C. TRH (1 microM TRH, a maximally effective dose) caused a marked transient decrease in TRH-R mRNA that attained a nadir of 20-45% of control by 3-6 h, increased after 9 h, but was still below control levels after 24 h. Elevation of the cytoplasmic free Ca2+ concentration had no effect on TRH-R mRNA. A maximally effective dose of PMA (1 microM) caused decreases in TRH-R mRNA that were similar in magnitude and time course to those induced by 1 microM TRH. H-7 (20 microM) blocked the effects of TRH and PMA to lower TRH-R mRNA to similar extents.(ABSTRACT TRUNCATED AT 250 WORDS)     

Regulation by thyrotropin-releasing hormone (TRH) of TRH receptor mRNA degradation in rat pituitary GH3 cells.

In rat pituitary GH3 cells, thyrotropin-releasing hormone (TRH) down-regulates TRH receptor (TRH-R) mRNA (Fujimoto, J., Straub, R.E., and Gershengorn, M.C. (1991) Mol. Endocrinol. 5, 1527-1532), at least in part, by stimulating its degradation (Fujimoto, J., Narayanan, C.S., Benjamin, J.E., Heinflink, M., and Gershengorn, M.C. (1992) Endocrinology 130, 1879-1884). Here we show that TRH regulates RNase activity in GH3 cells and that specific mRNA sequences are needed for in vivo regulation of TRH-R mRNA by TRH. TRH affected RNase activity in a biphasic manner with rapid stimulation (by 10 min) followed by a decrease to a rate slower than in control lysates within 6 h. This time course paralleled the effects of TRH on degradation of TRH-R mRNA in vivo. The regulated RNase activity was in a polysome-free fraction of the lysates and was not specific for TRH-R RNA. A truncated form of TRH-R RNA that was missing the entire 3'-untranslated region (TRHR-R5) was more stable than full-length TRH-R RNA (TRHR-WT). In contrast to TRHR-WT mRNA, TRHR-R5 mRNA and TRHR-D9 mRNA, which was missing the 143 nucleotides 5' of the poly(A) tail, were not down-regulated by TRH in stably transfected GH3 cells as their rates of degradation were not increased. These data show that TRH regulates RNase activity in GH3 cells, that the 3'-untranslated region bestows decreased stability on TRH-R mRNA and that the 3' end of the mRNA is necessary for regulation by TRH of TRH-R mRNA degradation. We present an hypothesis that explains specific regulation of TRH-R mRNA degradation by TRH in GH3 pituitary cells.     

Generation of thyrotropin-releasing hormone receptor 1-deficient mice as an animal model of central hypothyroidism

To provide an animal model of central hypothyroidism, mice deficient in the TRH-receptor 1 (TRH-R1) gene were generated by homologous recombination. The pituitaries of TRH-R1-/- mice are devoid of any TRH-binding capacity, demonstrating that TRH-R1 is the only receptor localized on TRH target cells of the pituitary. With the exception of some retardation in growth rate, TRH-R1-/- mice appear normal, but compared with control animals they exhibit a considerable decrease in serum T(3), T(4), and prolactin (PRL) levels but not in serum TSH levels. In situ hybridization histochemistry and real-time RT-PCR analysis revealed that in adult TRH-R1-/- animals TSHbeta-mRNA expression is not impaired whereas PRL mRNA and GH mRNA levels are considerably reduced compared with control mice. The numbers of thyrotropes, somatotropes, and lactotropes, however, are not affected by the deletion of the TRH-R1 gene. The mutant mice are fertile, and the dams nourish their pups well, indicating that TRH is not a decisive factor for suckling-induced PRL release. In situ hybridization and quantitative RT-PCR analysis, furthermore, revealed that, as in control animals, pituitary PRL-mRNA expression in TRH-R1-/- is considerably increased during lactation, albeit strongly reduced as compared with lactating control animals.     

A study on the localization and distribution of GnRH and its receptor in rat submaxillary glands by immunohistochemical,in situ hybridization and RT-PCR

We investigated the rat submaxillary gland for the presence of GnRH and GnRH receptors, the localization and colocalization of GnRH, GnRH receptor and their mRNA, and studied the sequence of GnRH receptor complementary DNA (cDNA) by immunohistochemistry, in situ hybridization and RT-PCR. The results showed that GnRH and GnRH receptor immunoreactive materials were colocalized in the epithelial cells of the serous acinus and glandular duct. The GnRH and GnRH receptor mRNA hybridization signals were detected in the above cells. The sequence obtained from the RT-PCR product was identical to the published cDNA sequence of GnRH receptor in the rat pituitary. The results suggested that the rat submaxillary gland was capable of synthesizing GnRH and GnRH receptors. GnRH may be involved in the functional regulation of the submaxillary gland through autocrine or paracrine activity.     

Thyrotropin-releasing hormone receptor expression in thyroid follicular cells: a new paracrine role of C-cells?

Thyrotropin-releasing hormone (TRH) synthesized in the hypothalamus has the capability of inducing the release of thyroid-stimulating hormone (TSH) from the anterior pituitary, which in turn stimulates the production of thyroid hormones in the thyroid gland. Immunoreactivity for TRH and TRH-like peptides has been found in some tissues outside the nervous system, including thyroid. It has been demonstrated that thyroid C-cells express authentic TRH, affecting thyroid hormone secretion by follicular cells. Therefore, C-cells could have a paracrine role in thyroid homeostasis. If this hypothesis is true, follicular cells should express TRH receptors (TRH-Rs) for the paracrine modulation carried out by C-cells. In order to elucidate whether or not C-cell TRH production could act over follicular cells modulating thyroid function, we studied TRH-Rs expression in PC C13 follicular cells from rat thyroid, by means of immunofluorescence technique and RT-PCR analysis. We also investigated the possibility that C-cells present TRH-Rs for the autocrine control of its own TRH production. Our results showed consistent expression for both receptors, TRH-R1 and TRH-R2, in 6-23 C-cells, and only for TRH-R2 in PC C13 follicular cells. Our data provide new evidence for a novel intrathyroidal regulatory pathway of thyroid hormone secretion via paracrine/autocrine TRH signaling.